It’s not easy to tell when a dynamic system, filled with life, might reach a point of no return.
Clinical trials of an mRNA vaccine have begun, and researchers expect broadly positive outcomes in the fight against the widespread illness.
A review indicates that both cannabinoids and terpenes in cannabis show great promise as antivirals in laboratory research, and could be used to treat infections including COVID-19.
XBB. 1.5 and other subvariants do signal a change in how the virus is mutating. Here’s what this means for Australia and globally.
As children return to school, a new study sheds light on the infection patterns of the various COVID-19 virus variants in open-space learning.
The Omicron strain is driving a rapid increase in China, and is quicker to transmit than other variants.
Why compassion should be paired with personal responsibility to deal with new pandemic waves.
Unclear and often mixed messages have contributed to public confusion that has arguably placed people’s health at risk.
A new book based on the world’s largest multi-professional study of its kind relates the distressing experiences of Australian healthcare workers amid the pandemic.
Just because we’re in a period of social change doesn’t mean we have to lose momentum on sustainability. There are six things we can do right now to offset our daily waste from disposable masks.
2022 will be the year we finally have all the means, measures, and tools to control the pandemic to a non-lethal state.
We tend to think of “psychedelics” as illegal, mind-altering substances, but they might just be the key to unlocking a revolution in mental health treatment.
The new variant of interest, detected in 42 countries, possesses a “constellation of mutations that indicate potential properties of immune escape”.
While data to the end of January 2021 shows suicide didn’t increase in COVID-stricken Victoria, there’s still deep concern about the longer-term effects of the pandemic on mental health.
Hard and fast lockdowns might seem harsh, but they’re a luxury many nations don’t have, and with large unvaccinated populations, the implications are potentially catastrophic. Just ask Indonesia.
We have the means, but how do you convince people to follow public health advice such as lockdowns?
The lack of investment in the development and deployment of decentralised diagnostic devices in Australia, most importantly a COVID-19 nucleic acid test, is a public policy failure.
The rapidly-mutating SARS-CoV-2 virus is testing the resilience of the world’s responses, with some variants evolving to become more infectious, and threatening a third wave.
How do we measure if people are following the health orders, and whether they’re having any effect?
The case is growing stronger for COVID-19 vaccine mixing-and-matching, with recent data showing high efficacy and protection against SARS-CoV-2 virus strains.
The decision to enact a lockdown is understandable, if disappointing, to Victorians, given the increasing COVID cases, contacts, and the virus’ “variant of concern”.
The backdrop of the pandemic, and yet another terror-inducing mass murder, amplifies the need for content moderation, and a preparedness to fact-check the fact-checkers.
Scientists are well-advanced in mapping the way forward to develop and repurpose medicines for respiratory virus patients in the post-COVID era.
Dr Harry Al-Wassiti, Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS), answers the questions about the jab that's on everyone's mind.
Dummy text
